dipen 100ml suspension for injection for cattle, sheep and pigs
bimeda animal health limited - procaine benzylpenicillin; dihydrostreptomycin sulfate - suspension for injection - 200, 200 milligram(s)/millilitre - penicillins, combinations with other antibacterials
bimoxyl la 150 mg/ml suspension for injection
bimeda animal health limited - amoxicillin trihydrate - suspension for injection - 150 milligram(s)/millilitre - amoxicillin
procillin 300 mg/ml suspension for injection for cattle, sheep and pigs
bimeda animal health limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin
ultrapen la 300 mg/ml suspension for injection
norbrook laboratories (ireland) limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin
norocillin 300 mg/ml suspension for injection
norbrook laboratories (ireland) limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - benzylpenicillin
invega hafyera paliperidone (as palmitate) 1000 mg in 5 ml modified release suspension for injection pre-filled syringe
janssen-cilag pty ltd - paliperidone palmitate, quantity: 1560 mg - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - invega hafyera, a 6-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months or the 3-month paliperidone palmitate injectable product following at least one 3-month injection cycle.
invega hafyera paliperidone (as palmitate) 700 mg in 3.5 ml modified release suspension for injection pre-filled syringe
janssen-cilag pty ltd - paliperidone palmitate, quantity: 1092 mg - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - invega hafyera, a 6-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months or the 3-month paliperidone palmitate injectable product following at least one 3-month injection cycle.
trumenba (meningococcal group b vaccine) suspension for injection pre-filled syringe
pfizer australia pty ltd - neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily a, quantity: 60 microgram; neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily b, quantity: 60 microgram - injection, suspension - excipient ingredients: water for injections; aluminium phosphate; histidine; sodium chloride; polysorbate 80 - trumenba is indicated in individuals 10 years and older for active immunisation to prevent invasive meningococcal disease caused by neisseria meningitidis serogroup b.
depodur morphine sulfate pentahydrate 10 mg/1 ml suspension for injection vial
aspen pharmacare australia pty ltd - morphine sulfate pentahydrate, quantity: 10 mg/ml - injection, suspension - excipient ingredients: dioleoylphosphatidylcholine; dipalmitoylphosphatidylglycerol; cholesterol; triolein; tricaprylin; sodium chloride; dilute hydrochloric acid; water for injections - for the relief of post-operative pain following major orthopaedic, abdominal, or pelvic surgery via the lumbar epidural route at a maximum recommended dose of 10 mg. appropriate monitoring must be maintained for at least 48 hours - see precautions.
invega trinza paliperidone (as palmitate) 525 mg modified release suspension for injection pre-filled syringe
janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.